BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Pfizer Inc. (PFE) and the Incredible Shrinking Sales Force


12/3/2012 7:56:47 AM

Once again, Pfizer is cutting its sales force. As part of what has become a never-ending reorganization, the drugmaker is eliminating between 10 percent and 20 percent of its primary care sales team across the US, according to sources. Formal notification is expected to be issued to employees by December 20. The precise number of jobs to be cut is unclear and a Pfizer spokesman declined to provide specifics or state how many sales reps the drugmaker currently employs in its primary care teams or in total in the US. But he did acknowledge in an e-mail that cuts are going to be made. “As part of our strategy to allocate our resources, investments and people to the areas that best serve our patients and customers, we continually evaluate how we can be more efficient and effective,” a Pfizer spokesman writes us. “As a result, we are making changes in some segments of our field force to better match the future needs of the business. Our US field force is a valued resource that we remain committed to developing throughout this period of change.”

Read at Pharmalot
Read at News Release
Read at Nasdaq
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES